相关实验视频
Updated: Jul 17, 2025
05:07
Microwave-Assisted Preparation of 1-Aryl-1H-pyrazole-5-amines
Published on: June 23, 2019
6.7K
基于Pyrazole-Thiadiazole的EGFR抑制剂的合成和抗癌活性
Berkant Kurban1,2, Begüm Nurpelin Sağlık2,3, Derya Osmaniye2,3
1Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Afyonkarahisar Health Sciences University, Afyonkarahisar 03030, Turkey.
ACS omega
|September 4, 2023
概括
新的EGFR抑制剂含有蒂亚迪亚和皮拉环,对肺癌治疗具有前途. 化合物6g表现出显著的活性,抑制了表皮生长因子受体 (EGFR) 酶.
科学领域:
- 药用化学 医学化学
- 在瘤学瘤学.
- 计算化学计算化学
背景情况:
- 肺癌是癌症死亡的主要原因之一.
- 表皮生长因子受体 (EGFR) 是肺癌治疗的关键标.
- EGFR抑制剂提供了一个有前途的治疗途径.
研究的目的:
- 开发新的EGFR抑制剂,使用亚二醇和酸支架.
- 评估合成化合物对肺癌细胞的体外和体外活性.
- 为了确定向EGFR的强效抑制剂.
主要方法:
- 在体外细胞毒性测定 (MTT) 和线粒体膜潜力 (MMP) 分析.
- EGFR酶抑制测定. 在 EGFR 酶抑制测定.
- 分子对接和分子动力学模拟用于in silico评估.
主要成果:
- 化合物6d,6g和6j对A549肺癌细胞系表现出抑制活性.
- 化合物6g显示出显著的MMP (80.93%) 和强大的EGFR抑制 (IC50 = 0.024 ± 0.002μM).
- 在的研究支持合成化合物的抑制潜力.
结论:
- 新型蒂亚迪亚和皮拉衍生物是有效的EGFR抑制剂.
- 化合物6g是进一步开发肺癌治疗的有希望的候选物.
- 该研究强调了这些支架在向癌症治疗中的潜力.
相关概念视频
02:38Mitogens and the Cell Cycle
6.6K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
02:57Targeted Cancer Therapies
7.7K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.7K